Abstract
Background: Clinical studies have shown that the efficacy of programmed cell death receptor-1/programmed cell death ligand-1 (PD-1/PD-L1) inhibitors o......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
